Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Katharina, Hammer"'
Autor:
Najib Ben Khaled, Katharina Hammer, Liangtao Ye, Ahmed Alnatsha, Sebastian A. Widholz, Ignazio Piseddu, Simon Sirtl, Julia Schneider, Stefan Munker, Ujjwal Mukund Mahajan, Juan José Montero, Joscha Griger, Julia Mayerle, Florian P. Reiter, Enrico N. De Toni
Publikováno v:
Cancers, Vol 14, Iss 21, p 5240 (2022)
Chemotherapy, the standard treatment for pancreatic ductal adenocarcinoma (PDAC), has only a modest effect on the outcome of patients with late-stage disease. Investigations of the genetic features of PDAC have demonstrated a frequent occurrence of m
Externí odkaz:
https://doaj.org/article/b86d94d5f7a44c51876f39a7675ca1d0
Autor:
Daniel Roessler, Osman Öcal, Alexander B. Philipp, Daniel Markwardt, Stefan Munker, Julia Mayerle, Leonie S. Jochheim, Katharina Hammer, Christian M. Lange, Andreas Geier, Max Seidensticker, Florian P. Reiter, Enrico N. De Toni, Najib Ben Khaled
Publikováno v:
Journal of cancer research and clinical oncology.
Introduction Immune checkpoint inhibitor (ICI)-based regimens are transforming the landscape of hepatocellular carcinoma (HCC) treatment. We describe the effect of combined ipilimumab and nivolumab in patients with advanced HCC after the failure of p
Autor:
Peter Schemmer, Michael Behr, Li Liu, Ingrid Herr, Dirk M. Nettelbeck, Adam Kazcorowski, Katharina Hammer
Publikováno v:
International Journal of Cancer. 137:978-990
Oncolytic viruses have demonstrated in pre-clinical and clinical studies safety and a unique pleiotropic activity profile of tumor destruction. Yet, their delivery suffers from virus inactivation by blood components and sequestration to healthy tissu
Autor:
Roland E. Kontermann, Sarah Engelhardt, Inés Fernández-Ulibarri, Jochen Hess, Dominik E. Dorer, Heike Allgayer, Jürgen Krauss, Michaela A. E. Arndt, Dirk M. Nettelbeck, Johanna K. Kaufmann, Katharina Hammer
Publikováno v:
International Journal of Cancer. 136:2228-2240
Antibody therapy of solid cancers is well established, but suffers from unsatisfactory tumor penetration of large immunoglobulins or from low serum retention of antibody fragments. Oncolytic viruses are in advanced clinical development showing excell
Autor:
Terence S. Dermody, Karl W. Boehme, Katharina Hammer, Jennifer L. Konopka-Anstadt, Takeshi Kobayashi, William C. Tollefson
Publikováno v:
Journal of Virology
Reovirus nonstructural protein σ1s is implicated in cell cycle arrest at the G 2 /M boundary and induction of apoptosis. However, the contribution of σ1s to these effects in an otherwise isogenic viral background has not been defined. To evaluate t
Autor:
Nima Memaran, Karin Hammer, Veronika Hammer, Katharina Hammer, Wolf-Dietrich Huber, Johann Hammer
Publikováno v:
Digestive Diseases and Sciences. 63:1670-1670
Limited valid data are available regarding the association of fructose-induced symptoms, fructose malabsorption, and clinical symptoms.To develop a questionnaire for valid symptom assessment before and during a carbohydrate breath test and to correla
Autor:
Katharina, Hammer, Adam, Kazcorowski, Li, Liu, Michael, Behr, Peter, Schemmer, Ingrid, Herr, Dirk M, Nettelbeck
Publikováno v:
International journal of cancer. 137(4)
Oncolytic viruses have demonstrated in pre-clinical and clinical studies safety and a unique pleiotropic activity profile of tumor destruction. Yet, their delivery suffers from virus inactivation by blood components and sequestration to healthy tissu
Autor:
Inés, Fernández-Ulibarri, Katharina, Hammer, Michaela A E, Arndt, Johanna K, Kaufmann, Dominik, Dorer, Sarah, Engelhardt, Roland E, Kontermann, Jochen, Hess, Heike, Allgayer, Jürgen, Krauss, Dirk M, Nettelbeck
Publikováno v:
International journal of cancer. 136(9)
Antibody therapy of solid cancers is well established, but suffers from unsatisfactory tumor penetration of large immunoglobulins or from low serum retention of antibody fragments. Oncolytic viruses are in advanced clinical development showing excell
Publikováno v:
Archives of toxicology. 87(4)
Signaling through the WNT/β-catenin and the RAS (rat sarcoma)/MAPK (mitogen-activated protein kinase) pathways plays a key role in the regulation of various physiological cellular processes including proliferation, differentiation, and cell death. A